人体深静脉血栓中XI因子的局部化以及激活的XI因子对静脉血栓形成和血液静止的作用
Nobuyuki Oguri1, Toshihiro Gi1, Eriko Nakamura1
1Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Research and practice in thrombosis and haemostasis
|April 16, 2025
概括
因素XI (FXI) 在人类深静脉血栓塞 (DVT) 中存在. 与FXa抑制剂相比,FXIa抑制剂显示出治疗DVT的潜力,对血液静止的影响较小.
科学领域:
- 血液学 血液学 血液学
- 血栓形成研究研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对凝血因子 (F) XI/激活的FXI (FXIa) 的新型抗凝剂正在开发中.
- 人体深静脉血栓形成 (DVT) 中FXI的存在以及FXIa和激活FX (FXa) 在血栓形成和血液静止中的不同作用仍然不清楚.
研究的目的:
- 为了确定FXI在人体DVT中的存在.
- 在子模型中研究直接口服FXIa和FXa抑制剂对静脉血栓形成和血液静止的作用.
- 评估对体外血栓形成的影响.
主要方法:
- 在人体DVT样本中对FXI定位的免疫组织化学评估 (n=15).
- 在接受FXIa抑制剂 (ONO-1600586) 与FXa抑制剂 (rivaroxaban) 治疗的子中,对血栓形成,出血时间和体积的比较分析.
- 子和人类血液在低剪切条件下 (70/s) 在流体室内进行ex vivo perfusion.
主要成果:
- 在所有DVT中都局部存在FXI,主要是在纤维素丰富和非组织区域.
- 两种FXIa和FXa抑制剂相对抑制了静脉血栓的形成.
- FXIa抑制剂没有显著影响子的出血时间或体积,而FXa抑制剂显示出更强烈的纤维素形成抑制.
- 在 perfusion 研究中,FXIa 抑制剂抑制了人类的FXIa活性,血栓生成和纤维素形成.
结论:
- 病理学发现证实了FXI在人体DVT中的作用.
- 与FXa抑制剂相比,FXIa抑制剂可能表现出纤维素形成的减少,这表明其在血液静止中的作用可能较小.
- 这些发现支持开发用于DVT治疗的FXIa抑制剂,其在出血风险方面具有潜在有利的安全性.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
548
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
548
Extrinsic and Intrinsic Pathways of Hemostasis
4.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.2K
Clot Retraction and Fibrinolysis
2.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.9K
Coagulation
3.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.7K
Formation of the Platelet Plug
3.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.3K
Introduction to Hemostasis
4.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.5K


